China NMPA Issues New Regulations on Designating Domestic Agents for Overseas Drug MAH Compliance
November 14, 2024 In China, RPPV plays an essential part in the Good Pharmacovigilance Practice (hereinafter “China GVP”) and the Inspection Guideline for Pharmacovigilance (hereinafter “PV Inspection Guideline”), both were released by National Medical Products Administration (NMPA) in May 2021 and April 2022 respectively. The National Medical Products Administration (NMPA) has officially released the Interim…